Navigation Links
Starch Medical Launches Novel Plant Sourced Surgical Hemostatic Pad
Date:10/20/2009

SAN JOSE, Calif., Oct. 20 /PRNewswire/ -- Starch Medical Inc (SMI), a San Jose, CA-based medical device manufacturer, announces the first controlled clinical intro/launch of SealFoam(TM) Absorbable Polysaccharide Hemostat in the European Union and other major international markets. Introduction of SealFoam(TM) Absorbable Polysaccharide Hemostat will commence this month at the European Association of Cardio-Thoracic Surgeons congress in Vienna and in November at the MEDICA congress in Dusseldorf, Germany (booth #16E20).

SealFoam(TM) is the latest addition to the Absorbable Modified Polymer (AMP(TM)) product line and offers a hemostatic foam (pad) configuration for a wide range of surgical wounds. The ultra hydrophilic and adhesive properties of SealFoam(TM) are especially formulated to control oozing or profuse bleeding, and to minimize the possibility of re-bleeding. The pad may also be trimmed to suit the surgical procedure and is indicated for a diverse range of applications and unique wound contours.

AMP(TM) technology is a proprietary engineering process that modifies plant starch into biocompatible, absorbable, hemostatic polysaccharide particles. AMP(TM) particles have a molecular structure that rapidly absorbs water from blood, causing a high concentration of platelets, red blood cells and coagulation proteins which accelerate the physiologic clotting cascade at the bleeding site.

David Lang, President of SMI, states "SealFoam(TM) is currently the only available surgical hemostatic pad derived from plant starch without animal/human components. The superb efficacy offers surgeons a safe alternative for achieving hemostasis under various surgical conditions. We will introduce SealFoam(TM) through our global distribution network and potential partners during the 4th quarter of this year."

SMI is a privately-held medical device company engaged in the design, manufacture, marketing and licensing of breakthrough, hemostatic solutions. Starch Medical's proprietary, patent-pending technology platform (AMP(TM)), including powders, foams and films, will focus on the worldwide, multi-billion dollar biomaterial, hemostasis, and wound care marketplace.

For additional information, distribution inquiries, and licensing options, please visit www.starchmedical.com.

Contact: Jane Chen of Starch Medical Inc, +1-408-428-9818, jane@starchmedical.com

SOURCE Starch Medical Inc


'/>"/>
SOURCE Starch Medical Inc
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. You May Have a Thyroid Problem and Not Know It - Particularly If Youre Over 60, Says a New Harvard Medical School Report
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. Globus Medical Raises $110 Million in Series E Financing Round
5. Quark Pharmaceuticals Appoints New Chief Medical Officer
6. Boston University Biomedical Engineers Find Chink in Bacterias Armor
7. Rochester Medical Anti-Infection Foley Catheter Demonstrates Effectiveness in Randomized Trial
8. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Cleveland Clinic Summits to Focus on Cardiovascular Medical Innovation
11. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... Pa. , Oct. 10, 2017   West ... in innovative solutions for injectable drug administration, today shared ... West,s ID Adapter for improving the intradermal administration of ... Fourth Skin Vaccination Summit in May 2017 by Dr. ... Lead, Polio Department, World Health Organization (WHO), and recently ...
(Date:10/4/2017)... LAWRENCE, Mass. , Oct. 4, 2017 /PRNewswire/ ... developer of single-use, self-contained, illuminating medical devices, today ... National Health Surveillance Agency (or Agência Nacional ... ®. The first single-use, cordless surgical retractor with ... ONETRAC provides optimal access, illumination and exposure of ...
(Date:10/2/2017)... , Oct. 2, 2017 The Rebound mobile app ... struggle to reverse the tide of prescription drug addiction. The ... their medicine intake and stepping down their dosage in a ... launch in December 2017; the first 100,000 people to sign ... at http://www.rebound-solution.com/ ...
Breaking Medicine Technology:
(Date:10/13/2017)... Ill. (PRWEB) , ... October ... ... Edwardsville School of Pharmacy (SOP) alumni Hannah Randall, PharmD ‘17, and Jennifer ... healthcare professionals on guideline updates for the primary prevention of cardiovascular diseases ...
(Date:10/13/2017)... ... , ... Apple Rehab Shelton Lakes , which specializes in the delivery ... as part of a disaster drill on October 3rd. , Apple Rehab participated with ... Manager, as well as the Connecticut Long Term Care Mutual Aid Plan (LTC-MAP). ...
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... The Visiting ... Day Market. Featuring a collection of specialty vendors and unique items from across the ... and quality-focused health and wellness services offered by the VNA. The boutique will ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids this ... by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited about ... ages; it is a non-competitive, non-timed event, which is all about having fun and ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... giving viewers the lowdown on sciatica in a new episode of "Success Files," ... on current events and innovation and investigates each subject in-depth with passion and ...
Breaking Medicine News(10 mins):